Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
Clinical trial NCT02267993 · COMPLETED
Trial details
- NCT number
- NCT02267993
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-08-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.